PALbociclib Endocrine Therapy Followed by Talazo vs. Talazoz-Atezo Study
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Premenopausal HR+/HER2- Metastatic Breast Cancer
Interventions: DRUG: Pabociclib, Endocrine, Talazoparib, Atezolizumab|DRUG: Pabociclib, Endocrine, Talazoparib,
Sponsor: Samsung Medical Center